The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 4, 2004, Pages 737-746

  Van Den Berge, Maarten ^a   Polosa, Riccardo ^a   Kerstjens, Huib A M ^a   Postma, Dirkje S ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

adenosine; AMP; hyperresponsiveness; inflammation

Indexed keywords

ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ANTIHISTAMINIC AGENT; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; ENPROFYLLINE; FLUTICASONE PROPIONATE; FORMOTEROL; HISTAMINE; KT 5720; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHACHOLINE; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CELL ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; ENZYME ACTIVITY; EOSINOPHIL; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; MAST CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SMOKING; SMOOTH MUSCLE; STIMULUS RESPONSE;

EID: 4944264987     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.05.071     Document Type: Article

References (103)

1. D.S. Postma, and H.A.M. Kerstjens Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease Am J Respir Crit Care Med 158 1998 S187 S192
2. R.E. Kanner, J.E. Connett, M.D. Altose, A.S. Buist, W.W. Lee, and D.P. Tashkin Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study Am J Respir Crit Care Med 150 1994 956 961
3. G.D. Phillips, W.H. Ng, M.K. Church, and S.T. Holgate The response of plasma histamine to bronchoprovocation with methacholine, adenosine 5′-monophosphate, and allergen in atopic nonasthmatic subjects Am Rev Respir Dis 141 1990 9 13
4. R. Polosa, W.H. Ng, N. Crimi, C. Vancheri, S.T. Holgate, and M.K. Church Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma Am J Respir Crit Care Med 151 1995 624 629
5. S.R. Rutgers, G.H. Koeter, T.W. Van Der Mark, and D.S. Postma Protective effect of oral terfenadine and not inhaled ipratropium on adenosine 5′-monophosphate-induced bronchoconstriction in patients with COPD Clin Exp Allergy 29 1999 1287 1292
6. M. van den Berge, H.A.M. Kerstjens, and D.S. Postma Provocation with adenosine 5′-monophosphate as a marker of inflammation in asthma, allergic rhinitis and chronic obstructive pulmonary disease Clin Exp Allergy 32 2002 824 830
7. M. van den Berge, R.J. Meijer, H.A.M. Kerstjens, D.M. de Reus, G.H. Koeter, and H.F. Kauffman PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine Am J Respir Crit Care Med 163 2001 1546 1550
8. R. Polosa, I. Ciamarra, G. Mangano, G. Prosperini, M.P. Pistorio, and C. Vancheri Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis Eur Respir J 15 2000 30 35
9. G.F. Joos, B. O'Connor, S.D. Anderson, F. Chung, D.W. Cockcroft, and B. Dahlen Indirect airway challenges Eur Respir J 21 2003 1050 1068
10. M.A. Martinez-Garcia, M. Perpina-Tordera, V. Vila, L. Compte-Torrero, A. Diego-Damia, and V. Macian-Gisbert Analysis of the stability of stored adenosine 5′-monophosphate used for bronchoprovocation Pulm Pharmacol Ther 15 2002 157 160
11. M.J. Cushley, N. Tallant, and S.T. Holgate The effect of dipyridamole on histamine- and adenosine-induced bronchoconstriction in normal and asthmatic subjects Eur J Respir Dis 67 1985 185 192
12. N. Crimi, F. Palermo, R. Oliveri, C. Maccarrone, B. Palermo, and C. Vancheri Enhancing effect of dipyridamole inhalation on adenosine-induced bronchospasm in asthmatic patients Allergy 43 1988 179 183
13. M.G. Collis, and S.M. Hourani Adenosine receptor subtypes Trends Pharmacol Sci 14 1993 360 366
14. B.A. Walker, M.A. Jacobson, D.A. Knight, C.A. Salvatore, T. Weir, and D. Zhou Adenosine A3 receptor expression and function in eosinophils Am J Respir Cell Mol Biol 16 1997 531 537
15. R. Marquardt, J. Fischer, and W. Kustner Effect of arterial hypoxia and acidosis on fibrillation threshold in the cat heart in vivo Z Kardiol 65 1976 585 589 [in German]
16. I. Feoktistov, and I. Biaggioni Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma J Clin Invest 96 1995 1979 1986
17. D.L. Marquardt, and L.L. Walker Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness Agents Actions 43 1994 7 12
18. A.G. Driver, C.A. Kukoly, S. Ali, and S.J. Mustafa Adenosine in bronchoalveolar lavage fluid in asthma Am Rev Respir Dis 148 1993 91 97
19. J.S. Mann, S.T. Holgate, A.G. Renwick, and M.J. Cushley Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma J Appl Physiol 61 1986 1667 1676
20. M. van den Berge, H.A.M. Kerstjens, D.M. de Reus, G.H. Koeter, H.F. Kauffman, and D.S. Postma Provocation with adenosine 5′-monophosphate, but not methacholine, induces sputum eosinophilia Clin Exp Allergy 34 2004 71 76
21. A.F. Walls, S. He, L.M. Teran, M.G. Buckley, K.S. Jung, and S.T. Holgate Granulocyte recruitment by human mast cell tryptase Int Arch Allergy Immunol 107 1995 372 373
22. S. He, and A.F. Walls Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo Br J Pharmacol 125 1998 1491 1500
23. S.J. Compton, J.A. Cairns, S.T. Holgate, and A.F. Walls Interaction of human mast cell tryptase with endothelial cells to stimulate inflammatory cell recruitment Int Arch Allergy Immunol 118 1999 204 205
24. G.M. Gauvreau, K.N. Parameswaran, R.M. Watson, and P.M. O'Byrne Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma Am J Respir Crit Care Med 164 2001 1495 1500
25. Z. Diamant, J.T. Hiltermann, E.L. van Rensen, P.M. Callenbach, M. Veselic-Charvat, and H. van der Veen The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma Am J Respir Crit Care Med 155 1997 1247 1253
26. A. Mulder, G.M. Gauvreau, R.M. Watson, and P.M. O'Byrne Effect of inhaled leukotriene D4 on airway eosinophilia and airway hyperresponsiveness in asthmatic subjects Am J Respir Crit Care Med 159 1999 1562 1567
27. N. Hirata, H. Kohrogi, H. Iwagoe, E. Goto, J. Hamamoto, and K. Fujii Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus: time course and the role of cytokines Am J Respir Cell Mol Biol 18 1998 12 20
28. K. Blease, J. Seybold, I.M. Adcock, P.G. Hellewell, and A. Burke-Gaffney Interleukin-4 and lipopolysaccharide synergize to induce vascular cell adhesion molecule-1 expression in human lung microvascular endothelial cells Am J Respir Cell Mol Biol 18 1998 620 630
29. 2 generation, respectively J Clin Invest 85 1990 1150 1157
30. A. Felsch, K. Stocker, and U. Borchard Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists J Immunol 155 1995 333 338
31. H. Suzuki, M. Takei, T. Nakahata, and H. Fukamachi Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI Biochem Biophys Res Commun 242 1998 697 702
32. J.L. Chunn, H.W. Young, S.K. Banerjee, G.N. Colasurdo, and M.R. Blackburn Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice J Immunol 167 2001 4676 4685
33. H. Zhong, J.L. Chunn, J.B. Volmer, J.R. Fozard, and M.R. Blackburn Adenosine-mediated mast cell degranulation in adenosine deaminase-deficient mice J Pharmacol Exp Ther 298 2001 433 440
34. J.R. Fozard, K.M. Ellis, M.F. Villela Dantas, B. Tigani, and L. Mazzoni Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat Eur J Pharmacol 438 2002 183 188
35. J.W. Nyce, and W.J. Metzger DNA antisense therapy for asthma in an animal model Nature 385 1997 721 725
36. S. Lim, K. Tomita, G. Carramori, A. Jatakanon, B. Oliver, and A. Keller Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma Am J Respir Crit Care Med 164 2001 273 276
37. T. Morali, A. Yilmaz, F. Erkan, E. Akkaya, F. Ece, and R. Baran Efficacy of inhaled budesonide and oral theophylline in asthmatic subjects J Asthma 38 2001 673 679
38. P. Sullivan, S. Bekir, Z. Jaffar, C. Page, P. Jeffery, and J. Costello Anti-inflammatory effects of low-dose oral theophylline in atopic asthma Lancet 343 1994 1006 1008
39. I. Feoktistov, R. Polosa, S.T. Holgate, and I. Biaggioni Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 19 1998 148 153
40. K.N. Klotz, J. Hessling, J. Hegler, C. Owman, B. Kull, and B.B. Fredholm Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells Naunyn Schmiedebergs Arch Pharmacol 357 1998 1 9
41. D.J. Evans, D.A. Taylor, O. Zetterstrom, K.F. Chung, B.J. O'Connor, and P.J. Barnes A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma N Engl J Med 337 1997 1412 1418
42. P.J. Barnes Therapy of chronic obstructive pulmonary disease Pharmacol Ther 97 2003 87 94
43. J.K. Sont, J. Han, J.M. van Krieken, C.E. Evertse, R. Hooijer, and L.N. Willems Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids Thorax 51 1996 496 502
44. R. Aalbers, J.G. de Monchy, H.F. Kauffman, M. Smith, Y. Hoekstra, and B. Vrugt Dynamics of eosinophil infiltration in the bronchial mucosa before and after the late asthmatic reaction Eur Respir J 6 1993 840 847
45. M.J. Alvarez, J.M. Olaguibel, B.E. Garcia, A. Rodriquez, A.I. Tabar, and E. Urbiola Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing Allergy 55 2000 355 362
46. E. Crimi, A. Spanevello, M. Neri, P.W. Ind, G.A. Rossi, and V. Brusasco Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma Am J Respir Crit Care Med 157 1998 4 9
47. B.L. Bradley, M. Azzawi, M. Jacobson, B. Assoufi, J.V. Collins, and A.M. Irani Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness J Allergy Clin Immunol 88 1991 661 674
48. B.R. Wiggs, C. Bosken, P.D. Pare, A. James, and J.C. Hogg A model of airway narrowing in asthma and in chronic obstructive pulmonary disease Am Rev Respir Dis 145 1992 1251 1258
49. M. Van den Berge, R.J. Meijer, H.A.M. Kerstjens, D.M. de Reus, G.H. Koeter, and H.F. Kauffman PC(20) adenosine 5′-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine Am J Respir Crit Care Med 163 2001 1546 1550
50. M. Van den Berge, H.A.M. Kerstjens, R.J. Meijer, D.M. de Reus, G.H. Koeter, and H.F. Kauffman Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine Am J Respir Crit Care Med 164 2001 1127 1132
51. J. Benckhuijsen, J.W. van den Bos, E. van Velzen, R. de Bruijn, and R. Aalbers Differences in the effect of allergen avoidance on bronchial hyperresponsiveness as measured by methacholine, adenosine 5′- monophosphate, and exercise in asthmatic children Pediatr Pulmonol 22 1996 147 153
52. G. Prosperini, K. Rajakulasingam, R.R. Cacciola, L. Spicuzza, S. Rorke, and S.T. Holgate Changes in sputum counts and airway hyperresponsiveness after budesonide: monitoring anti-inflammatory response on the basis of surrogate markers of airway inflammation J Allergy Clin Immunol 110 2002 855 861
53. D.A. Taylor, M.W. Jensen, V. Kanabar, R. Engelstatter, V.W. Steinijans, and P.J. Barnes A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5′-monophosphate in asthmatic patients Am J Respir Crit Care Med 160 1999 237 243
54. A. Avital, C. Springer, E. Bar-Yishay, and S. Godfrey Adenosine, methacholine, and exercise challenges in children with asthma or paediatric chronic obstructive pulmonary disease Thorax 50 1995 511 516
55. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721
56. B.J. O'Connor, S.M. Ridge, P.J. Barnes, and R.W. Fuller Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma Am Rev Respir Dis 146 1992 560 564
57. E.J. Weersink, R.R. Douma, D.S. Postma, and G.H. Koeter Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma Am J Respir Crit Care Med 155 1997 1241 1246
58. J. Doull, D. Sandall, S. Smith, J. Schreiber, N.J. Freezer, and S.T. Holgate Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5′ monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze Pediatr Pulmonol 23 1997 404 411
59. R.J. Meijer, H.A.M. Kerstjens, L.R. Arends, H.F. Kauffman, G.H. Koeter, and D.S. Postma Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma Thorax 54 1999 894 899
60. R.I. Ketchell, M.W. Jensen, P. Lumley, A.M. Wright, M.I. Allenby, and B.J. O'Connor Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma J Allergy Clin Immunol 110 2002 603 606
61. R.W. Fuller, N.B. Choudry, and G. Eriksson Action of budesonide on asthmatic bronchial hyperresponsiveness. Effects on directly and indirectly acting bronchoconstrictors Chest 100 1991 670 674
62. C.J. Reynolds, A. Togias, and D. Proud Airways hyperresponsiveness to bradykinin and methacholine: effects of inhaled fluticasone Clin Exp Allergy 32 2002 1174 1179
63. A.S. Vathenen, A.J. Knox, A. Wisniewski, and A.E. Tattersfield Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma Thorax 46 1991 811 816
64. W.B. Hofstra, H.J. Neijens, E.J. Duiverman, J.M. Kouwenberg, P.G. Mulder, and M.C. Kuethe Dose-responses over time to inhaled fluticasone propionate treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma Pediatr Pulmonol 29 2000 415 423
65. C.A. Groot, J.W. Lammers, J. Molema, J. Festen, and C.L. van Herwaarden Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsiveness to histamine and distilled water Eur Respir J 5 1992 1075 1082
66. G.P. Bootsma, P.N. Dekhuijzen, J. Festen, P.G. Mulder, and C.L. van Herwaarden Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma Thorax 50 1995 1044 1050
67. W.F. Grashoff, J.K. Sont, P.J. Sterk, P.S. Hiemstra, W.I. de Boer, and J. Stolk Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages Am J Pathol 151 1997 1785 1790
68. R. Kalenderian, L. Raju, W. Roth, L.B. Schwartz, B. Gruber, and A. Janoff Elevated histamine and tryptase levels in smokers' bronchoalveolar lavage fluid. Do lung mast cells contribute to smokers' emphysema? Chest 94 1988 119 123
69. H.M. Brown, G. Storey, and W.H. George Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma Br Med J 1 1972 585 590
70. S.R. Rutgers, W. Timens, N. Tzanakis, H.F. Kauffman, T.W. Van Der Mark, and G.H. Koeter Airway inflammation and hyperresponsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease Clin Exp Allergy 30 2000 657 662
71. P. Chanez, A.M. Vignola, T. O'Shaugnessy, I. Enander, D. Li, and P.K. Jeffery Corticosteroid reversibility in COPD is related to features of asthma Am J Respir Crit Care Med 155 1997 1529 1534
72. E. Pizzichini, M.M. Pizzichini, P. Gibson, K. Parameswaran, G.J. Gleich, and L. Berman Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis Am J Respir Crit Care Med 158 1998 1511 1517
73. S.R. Rutgers, G.H. Koeter, T.W. Van Der Mark, and D.S. Postma Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5′-monophosphate in COPD Am J Respir Crit Care Med 157 1998 880 886
74. D.P. Tashkin, M.D. Altose, J.E. Connett, R.E. Kanner, W.W. Lee, and R.A. Wise Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group Am J Respir Crit Care Med 153 1996 1802 1811
75. D.S. Postma, J.B. Wempe, T.E. Renkema, T.W. Van Der Mark, and G.H. Koeter Hyperresponsiveness as a determinant of the outcome in chronic obstructive pulmonary disease Am Rev Respir Dis 143 1991 1458 1462
76. N.R. Anthonisen, J.E. Connett, and R.P. Murray Smoking and lung function of Lung Health Study participants after 11 years Am J Respir Crit Care Med 166 2002 675 679
77. P. Lange, S. Groth, G.J. Nyboe, J. Mortensen, M. Appleyard, and G. Jensen Effects of smoking and changes in smoking habits on the decline of FEV1 Eur Respir J 2 1989 811 816
78. Y. Oosterhoff, J.W. de Jong, M.A. Jansen, G.H. Koeter, and D.S. Postma Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking Am Rev Respir Dis 147 1993 553 558
79. Y. Oosterhoff, M.A. Jansen, D.S. Postma, and G.H. Koeter Airway responsiveness to adenosine 5′-monophosphate in smokers and nonsmokers with atopic asthma J Allergy Clin Immunol 92 1993 773 776
80. S.J. Fowler, O.J. Dempsey, E.J. Sims, and B.J. Lipworth Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype Am J Respir Crit Care Med 162 2000 1318 1322
81. D.W. Cockcroft How best to measure airway responsiveness Am J Respir Crit Care Med 163 2001 1514 1515
82. P.G. Gibson, C.J. Allen, J.P. Yang, B.J. Wong, J. Dolovich, and J. Denburg Intraepithelial mast cells in allergic and nonallergic asthma. Assessment using bronchial brushings Am Rev Respir Dis 148 1993 80 86
83. D. Robinson, Q. Hamid, A. Bentley, S. Ying, A.B. Kay, and S.R. Durham Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma J Allergy Clin Immunol 92 1993 313 324
84. G.D. Phillips, and S.T. Holgate Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5′-monophosphate in atopic and non-atopic asthma Clin Sci (Lond) 75 1988 429 436
85. B. Luijk, R.D. Kempsford, A.M. Wright, P. Zanen, and J.J. Lammers Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction Eur Respir J 23 2004 559 564
86. P. Bradding, and S.T. Holgate The mast cell as a source of cytokines in asthma Ann N Y Acad Sci 796 1996 272 281
87. P. Bradding, J.A. Roberts, K.M. Britten, S. Montefort, R. Djukanovic, and R. Mueller Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines Am J Respir Cell Mol Biol 10 1994 471 480
88. P. Bradding, I.H. Feather, S. Wilson, P.G. Bardin, C.H. Heusser, and S.T. Holgate Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation J Immunol 151 1993 3853 3865
89. P.J. Barnes Beta-adrenergic receptors and their regulation Am J Respir Crit Care Med 152 1995 838 860
90. P.T. Peachell, D.W. MacGlashan Jr., L.M. Lichtenstein, and R.P. Schleimer Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate J Immunol 140 1988 571 579
91. B.J. O'Connor, R.W. Fuller, and P.J. Barnes Nonbronchodilator effects of inhaled beta 2 agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma Am J Respir Crit Care Med 150 1994 381 387
92. E. Egbagbe, I.D. Pavord, P. Wilding, J. Thompson-Coon, and A.E. Tattersfield Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline Thorax 52 1997 239 243
93. R.I. Ketchell, M.W. Jensen, D. Spina, and B.J. O'Connor Dose-related effects of formoterol on airway responsiveness to adenosine 5′- monophosphate and histamine Eur Respir J 19 2002 611 616
94. D.A. Taylor, M.W. Jensen, S.L. Aikman, J.G. Harris, P.J. Barnes, and B.J. O'Connor Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma Am J Respir Crit Care Med 156 1997 1731 1737
95. M. Soler, L. Joos, C.T. Bolliger, S. Elsasser, and A.P. Perruchoud Bronchoprotection by salmeterol: cell stabilization or functional antagonism? Comparative effects on histamine- and AMP-induced bronchoconstriction Eur Respir J 7 1994 1973 1977
96. P.J. Barnes Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids Eur Respir J 19 2002 182 191
97. R.A. Pauwels, C.G. Lofdahl, D.S. Postma, A.E. Tattersfield, P. O'Byrne, and P.J. Barnes Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group N Engl J Med 337 1997 1405 1411
98. A.P. Greening, P.W. Ind, M. Northfield, and G. Shaw Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group Lancet 344 1994 219 224
99. A. Woolcock, B. Lundback, N. Ringdal, and L.A. Jacques Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am J Respir Crit Care Med 153 1996 1481 1488
100. S. Shrewsbury, S. Pyke, and M. Britton Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA) BMJ 320 2000 1368 1373
101. I. Aziz, K.S. Tan, I.P. Hall, M.M. Devlin, and B.J. Lipworth Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol Eur Respir J 12 1998 580 584
102. B.J. O'Connor, S.L. Aikman, and P.J. Barnes Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma N Engl J Med 327 1992 1204 1208
103. L.K. Chong, A.H. Morice, W.W. Yeo, R.P. Schleimer, and P.T. Peachell Functional desensitization of beta agonist responses in human lung mast cells Am J Respir Cell Mol Biol 13 1995 540 546